Novel immunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase A.

Casey, Nicholas Paul; Fujiwara, Hiroshi; Ochi, Toshiki; Yasukawa, Masaki

Casey, Nicholas Paul; Fujiwara, Hiroshi; Ochi, Toshiki; Yasukawa, Masaki.

Afiliação

Casey NP; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime University , Toon, Ehime, Japan.
Fujiwara H; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime University , Toon, Ehime, Japan.
Ochi T; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime University , Toon, Ehime, Japan.
Yasukawa M; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime University , Toon, Ehime, Japan.

Oncoimmunology ; 5(11): e1239006, 2016.

Article em En | MEDLINE | ID: mdl-27999761

Palavras-chave

Adult T-cell leukemia/lymphoma; T-cell receptor gene; aurora kinase A; engineered T cell; immunotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão